[1]
A. K. Kuna, G. Seru, and G. V. Radha, “ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF IMATINIB MESYLATE AND ITS DIMER IMPURITY IN PHARMACEUTICAL FORMULATION BY REVERSE-PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY”, Asian J Pharm Clin Res, vol. 11, no. 3, pp. 136–139, Mar. 2018.